Mallinckrodt (MNK) is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty and generic pharmaceutical products and therapies. With locations in the US, Canada, Europe and Asia, we operate in two reportable segments— Specialty Brands and Specialty Generics. The Company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients.
Mallinckrodt is a company that is focused on its mission— Listening for needs and delivering solutions. We provide medicines to address unmet patient needs, stemming from over 155 years of using our core strengths, experience and expertise to help improve outcomes for underserved patients with severe and critical conditions.
In addition, culture is one of the most important aspects of our organization. We are committed to fostering our culture through the engagement, development and empowerment of all of our employees. We are anchored in our values of Patient Centricity, Innovation, Collaboration and Integrity. In addition, diversity, equity and inclusion are at the core of who we are, and as we execute on our strategy to deliver powerful, life-changing treatments for patients, we are strengthened by the value we derive from the varied identities, experiences, cultures and views of our employees. Our dynamic work environment provides unique experiences for employees to grow and develop.
We are moving forward – Come with us.
